Nucleation of sickle hemoglobin mixed with hemoglobin A: Experimental and theoretical studies of hybrid-forming mixtures

Maria Rotter, Donna Yosmanovich, Robin W. Briehl, Suzanna Kwong, Frank A. Ferrone

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Sickle hemoglobin (HbS) is a point mutation of the two β subunits in normal Hb (HbA) that leads to nucleated polymerization and accompanying pathology. We measured the rates of homogeneous and heterogeneous nucleation of HbS in the presence of up to 50% HbA under conditions in which hybrid HbAS molecules will also form. The replacement of 50% of HbS by HbA slows polymerization by factors of ∼100 in the physiological range, which is substantially less than previously thought. To provide a theoretical description of these data, we extended the double nucleation model for HbS polymerization to conditions in which hybridized mixtures are present. Measurements of homogeneous nucleation and the theory agree only when at least one of the molecules in the nucleus is not a hybrid. We attribute this to the necessary presence in the nucleus of a molecule that utilizes both β-subunit mutation sites in intermolecular contacts, whereas the remaining molecules engage only one of the mutation sites. Heterogeneous nucleation appears to require an even greater number of nonhybrid molecules, presumably because of the need for the nucleus to attach to the polymer as well as to form internal bonds. These results also provide insights into the pathophysiology of sickle cell disease, including the occasional severe events that strike persons in whom both HbS and HbA are expressed, a condition known as sickle trait. The studies reported here are necessary for understanding physiologically relevant polymerization in the presence of ligands as well as therapeutically relevant copolymerizing inhibitors.

Original languageEnglish (US)
Pages (from-to)2790-2797
Number of pages8
JournalBiophysical Journal
Volume101
Issue number11
DOIs
StatePublished - Dec 7 2011

Fingerprint

Hemoglobin A
Sickle Hemoglobin
Polymerization
Theoretical Models
Mutation
Sickle Cell Anemia
Point Mutation
Polymers
Pathology
Ligands

ASJC Scopus subject areas

  • Biophysics

Cite this

Nucleation of sickle hemoglobin mixed with hemoglobin A : Experimental and theoretical studies of hybrid-forming mixtures. / Rotter, Maria; Yosmanovich, Donna; Briehl, Robin W.; Kwong, Suzanna; Ferrone, Frank A.

In: Biophysical Journal, Vol. 101, No. 11, 07.12.2011, p. 2790-2797.

Research output: Contribution to journalArticle

Rotter, Maria ; Yosmanovich, Donna ; Briehl, Robin W. ; Kwong, Suzanna ; Ferrone, Frank A. / Nucleation of sickle hemoglobin mixed with hemoglobin A : Experimental and theoretical studies of hybrid-forming mixtures. In: Biophysical Journal. 2011 ; Vol. 101, No. 11. pp. 2790-2797.
@article{c2390279df324fd7b5990bd0481e8b86,
title = "Nucleation of sickle hemoglobin mixed with hemoglobin A: Experimental and theoretical studies of hybrid-forming mixtures",
abstract = "Sickle hemoglobin (HbS) is a point mutation of the two β subunits in normal Hb (HbA) that leads to nucleated polymerization and accompanying pathology. We measured the rates of homogeneous and heterogeneous nucleation of HbS in the presence of up to 50{\%} HbA under conditions in which hybrid HbAS molecules will also form. The replacement of 50{\%} of HbS by HbA slows polymerization by factors of ∼100 in the physiological range, which is substantially less than previously thought. To provide a theoretical description of these data, we extended the double nucleation model for HbS polymerization to conditions in which hybridized mixtures are present. Measurements of homogeneous nucleation and the theory agree only when at least one of the molecules in the nucleus is not a hybrid. We attribute this to the necessary presence in the nucleus of a molecule that utilizes both β-subunit mutation sites in intermolecular contacts, whereas the remaining molecules engage only one of the mutation sites. Heterogeneous nucleation appears to require an even greater number of nonhybrid molecules, presumably because of the need for the nucleus to attach to the polymer as well as to form internal bonds. These results also provide insights into the pathophysiology of sickle cell disease, including the occasional severe events that strike persons in whom both HbS and HbA are expressed, a condition known as sickle trait. The studies reported here are necessary for understanding physiologically relevant polymerization in the presence of ligands as well as therapeutically relevant copolymerizing inhibitors.",
author = "Maria Rotter and Donna Yosmanovich and Briehl, {Robin W.} and Suzanna Kwong and Ferrone, {Frank A.}",
year = "2011",
month = "12",
day = "7",
doi = "10.1016/j.bpj.2011.10.027",
language = "English (US)",
volume = "101",
pages = "2790--2797",
journal = "Biophysical Journal",
issn = "0006-3495",
publisher = "Biophysical Society",
number = "11",

}

TY - JOUR

T1 - Nucleation of sickle hemoglobin mixed with hemoglobin A

T2 - Experimental and theoretical studies of hybrid-forming mixtures

AU - Rotter, Maria

AU - Yosmanovich, Donna

AU - Briehl, Robin W.

AU - Kwong, Suzanna

AU - Ferrone, Frank A.

PY - 2011/12/7

Y1 - 2011/12/7

N2 - Sickle hemoglobin (HbS) is a point mutation of the two β subunits in normal Hb (HbA) that leads to nucleated polymerization and accompanying pathology. We measured the rates of homogeneous and heterogeneous nucleation of HbS in the presence of up to 50% HbA under conditions in which hybrid HbAS molecules will also form. The replacement of 50% of HbS by HbA slows polymerization by factors of ∼100 in the physiological range, which is substantially less than previously thought. To provide a theoretical description of these data, we extended the double nucleation model for HbS polymerization to conditions in which hybridized mixtures are present. Measurements of homogeneous nucleation and the theory agree only when at least one of the molecules in the nucleus is not a hybrid. We attribute this to the necessary presence in the nucleus of a molecule that utilizes both β-subunit mutation sites in intermolecular contacts, whereas the remaining molecules engage only one of the mutation sites. Heterogeneous nucleation appears to require an even greater number of nonhybrid molecules, presumably because of the need for the nucleus to attach to the polymer as well as to form internal bonds. These results also provide insights into the pathophysiology of sickle cell disease, including the occasional severe events that strike persons in whom both HbS and HbA are expressed, a condition known as sickle trait. The studies reported here are necessary for understanding physiologically relevant polymerization in the presence of ligands as well as therapeutically relevant copolymerizing inhibitors.

AB - Sickle hemoglobin (HbS) is a point mutation of the two β subunits in normal Hb (HbA) that leads to nucleated polymerization and accompanying pathology. We measured the rates of homogeneous and heterogeneous nucleation of HbS in the presence of up to 50% HbA under conditions in which hybrid HbAS molecules will also form. The replacement of 50% of HbS by HbA slows polymerization by factors of ∼100 in the physiological range, which is substantially less than previously thought. To provide a theoretical description of these data, we extended the double nucleation model for HbS polymerization to conditions in which hybridized mixtures are present. Measurements of homogeneous nucleation and the theory agree only when at least one of the molecules in the nucleus is not a hybrid. We attribute this to the necessary presence in the nucleus of a molecule that utilizes both β-subunit mutation sites in intermolecular contacts, whereas the remaining molecules engage only one of the mutation sites. Heterogeneous nucleation appears to require an even greater number of nonhybrid molecules, presumably because of the need for the nucleus to attach to the polymer as well as to form internal bonds. These results also provide insights into the pathophysiology of sickle cell disease, including the occasional severe events that strike persons in whom both HbS and HbA are expressed, a condition known as sickle trait. The studies reported here are necessary for understanding physiologically relevant polymerization in the presence of ligands as well as therapeutically relevant copolymerizing inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=82955169512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955169512&partnerID=8YFLogxK

U2 - 10.1016/j.bpj.2011.10.027

DO - 10.1016/j.bpj.2011.10.027

M3 - Article

C2 - 22261068

AN - SCOPUS:82955169512

VL - 101

SP - 2790

EP - 2797

JO - Biophysical Journal

JF - Biophysical Journal

SN - 0006-3495

IS - 11

ER -